n Cardiovascular Journal of South Africa - Significant reduction in heart attacks in patients taking Pfizer's Lipitor : drug trends in cardiology

Volume 15, Issue 5
  • ISSN : 1680-0745



Extracted from text ... Patients taking the cholesterol-lowering medicine atorvastatin calcium (Lipitor) experienced 47% fewer nonfatal heart attacks compared to patients receiving usual care, according to data presented in the Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE) at the annual American College of Cardiology meeting in New Orleans. Patients taking atorvastatin in the trial also experienced a 17% reduction in overall negative cardiovascular outcomes including cardiac death, heart attacks, strokes and hospitalisations, compared to patients treated with usual care. Patients treated with usual care received cholesterol-lowering therapies prescribed by their physicians which included lifestyle changes such as modifications in diet, weight loss, exercise ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error